skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar solo
Refinado por: tipo de recurso: Artículos eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
11
CD52 Expression in Mantle Cell Lymphoma
CD52 Expression in Mantle Cell Lymphoma
Material Type:
Artículo 		Añadir a Mi Portal

CD52 Expression in Mantle Cell Lymphoma

Bass, Adam J. ; Gong, Jerald ; Nelson, Ramona ; Rizzieri, David A.

Leukemia & lymphoma, 2002, Vol.43 (2), p.339-342 [Revista revisada por pares]

United States: Informa UK Ltd

Texto completo disponible

Citas Citado por
12
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Material Type:
Artículo 		Añadir a Mi Portal

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

Markey, Kate A. ; Schluter, Jonas ; Gomes, Antonio L.C. ; Littmann, Eric R. ; Pickard, Amanda J. ; Taylor, Bradford P. ; Giardina, Paul A. ; Weber, Daniela ; Dai, Anqi ; Docampo, Melissa D. ; Armijo, Gabriel K. ; Slingerland, Ann E. ; Slingerland, John B. ; Nichols, Katherine B. ; Brereton, Daniel G. ; Clurman, Annelie G. ; Ramos, Ruben J. ; Rao, Arka ; Bush, Amy ; Bohannon, Lauren ; Covington, Megan ; Lew, Meagan V. ; Rizzieri, David A. ; Chao, Nelson ; Maloy, Molly ; Cho, Christina ; Politikos, Ioannis ; Giralt, Sergio ; Taur, Ying ; Pamer, Eric G. ; Holler, Ernst ; Perales, Miguel-Angel ; Ponce, Doris M. ; Devlin, Sean M. ; Xavier, Joao ; Sung, Anthony D. ; Peled, Jonathan U. ; Cross, Justin R. ; van den Brink, Marcel R.M.

Blood, 2020-07, Vol.136 (1), p.130-136 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
13
Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Material Type:
Artículo 		Añadir a Mi Portal

Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Stein, Eytan M. ; De Botton, Stephane ; Cluzeau, Thomas ; Pigneux, Arnaud ; Liesveld, Jane L. ; Cook, Rachel J. ; Rousselot, Philippe ; Rizzieri, David A ; Braun, Thorsten ; Bixby, Dale L. ; Roboz, Gail J. ; Lebon, Delphine ; Heiblig, Mael ; Kelly, Michael J. ; Volkert, Angela ; Zhou, Li ; Kang-Fortner, Qing ; Roth, David A. ; Peterlin, Pierre

Blood, 2020-11, Vol.136 (Supplement 1), p.6-7 [Revista revisada por pares]

Elsevier Inc

Texto completo disponible

Citas Citado por
14
A phase I study with CP-4055 in patients with hematologic malignancies
A phase I study with CP-4055 in patients with hematologic malignancies
Material Type:
Artículo 		Añadir a Mi Portal

A phase I study with CP-4055 in patients with hematologic malignancies

O'Brien, S. M. ; Vey, N. ; Rizzieri, D. A. ; Kantarjian, H. M. ; Prebet, T. ; Ravandi, F. ; Jacobsen, T. F. ; Nilsson, B. I. ; Staudacher, K. ; Giles, F. J.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2532-2532 [Revista revisada por pares]

Texto completo disponible

Citas Citado por
15
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
Material Type:
Artículo 		Añadir a Mi Portal

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

Maung, Ko ; Ramalingam, Sendhilnathan ; Chaudhry, Mohammad ; Ren, Yi ; Jung, Sin-Ho ; Romero, Kristi ; Corbet, Kelly ; Chao, Nelson J ; Choi, Taewoong ; Diehl, Anna Mae ; Diehl, Louis ; Gasparetto, Cristina ; Horwitz, Mitchell ; Long, Gwynn Douglas ; Lopez, Richard D ; Rizzieri, David A ; Sarantopoulos, Stefanie ; Sullivan, Keith M ; Bashir, Mustafa R ; Sung, Anthony D Alpini, Gianfranco D.

PloS one, 2020-09, Vol.15 (9), p.e0238824-e0238824 [Revista revisada por pares]

San Francisco: Public Library of Science

Texto completo disponible

Citas Citado por
16
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Material Type:
Artículo 		Añadir a Mi Portal

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

Kantarjian, Hagop M. ; Begna, Kebede H. ; Altman, Jessica K. ; Goldberg, Stuart L. ; Sekeres, Mikkael A. ; Strickland, Stephen A. ; Arellano, Martha L. ; Claxton, David F. ; Baer, Maria R. ; Gautier, Marc ; Berman, Ellin ; Seiter, Karen ; Solomon, Scott R. ; Schiller, Gary J. ; Luger, Selina M. ; Butrym, Aleksandra ; Gaidano, Gianluca ; Thomas, Xavier G. ; Montesinos, Pau ; Rizzieri, David A. ; Quick, Donald P. ; Venugopal, Parameswaran ; Gaur, Rakesh ; Maness, Lori J. ; Kadia, Tapan M. ; Ravandi, Farhad ; Buyse, Marc E. ; Chiao, Judy H.

Cancer, 2021-12, Vol.127 (23), p.4421-4431 [Revista revisada por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponible

Citas Citado por
17
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artículo 		Añadir a Mi Portal

Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786-797 [Revista revisada por pares]

Texto completo disponible

Citas Citado por
18
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Material Type:
Artículo 		Añadir a Mi Portal

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation

SNYDER, Matthew J ; STENZEL, Timothy T ; BUCKLEY, Patrick J ; LAGOO, Anand S ; RIZZIERI, David A ; GASPARETTO, Cristina ; VREDENBURGH, James J ; CHAO, Nelson J ; GONG, Jerald Z

The American journal of surgical pathology, 2004-06, Vol.28 (6), p.794-800 [Revista revisada por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponible

Citas Citado por
19
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artículo 		Añadir a Mi Portal

Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786 [Revista revisada por pares]

United States

Texto completo disponible

Citas Citado por
20
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Material Type:
Artículo 		Añadir a Mi Portal

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia

O'Brien, Susan ; Rizzieri, David A. ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O. ; Sekeres, Mikkael A. ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A. ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis J.

British journal of haematology, 2012-09, Vol.158 (5), p.581-588 [Revista revisada por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Recursos en línea (4.060)
  2. Revistas arbitradas (3.730)
  3. Disponible (72)

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1990  (121)
  2. 1990Hasta1997  (264)
  3. 1998Hasta2005  (515)
  4. 2006Hasta2014  (1.670)
  5. Después de 2014  (2.026)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (3.964)
  2. Portugués  (617)
  3. Japonés  (541)
  4. Español  (28)
  5. Francés  (21)
  6. Alemán  (11)
  7. Polaco  (4)
  8. Noruego  (1)
  9. Chino  (1)
  10. Más opciones open sub menu

Nuevas sugerencias de búsqueda

Ignorar mi consulta y buscar por todo

por este autor/creador:

  1. Rizzieri, J
  2. Amaral, C
  3. Luque, C
  4. Lopes, L
  5. Montoro Filho, A

con este tema:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Oncology
  5. Hematology

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora